Message #67 From:
NewsBot Date: February 15, 2007 05:30:00 AM
EFSF News eFoodSafety.com, Inc. Announces Wall Street Resources, Inc. Releases an Analytical Profile on eFoodSafety.com, Inc. with 12-Month Target Value of $2.11
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB:EFSF), a Company dedicated to improving health conditions around the world through innovative products and technologies, today announced the release of an analytical profile on the Company by respected micro-cap analyst Paul Silver, Director of Research for Wall Street Resources, Inc., which contains a 12-month target value for EFSF of $2.11 per share.
The free report is available at: www.wallstreetresources.net/EFSFPP.asp. The 41-page report includes detailed information on the Company's business model, products, industry, valuation, management and risks. Wall Street Resources, Inc. is a professional research and consulting firm whose principals have over 15 years of experience providing analysis for emerging growth companies and information to the investment community.
Patricia Gruden, President and CEO of eFoodSafety.com, Inc. stated, “Our collaboration with Wall Street Resources in an effort to create an organized presentation showcasing our current products, technologies, and works in progress, resulted in a high-quality, in-depth analytical report on eFoodSafety and its subsidiaries. We remain dedicated to our shareholders for their ongoing support and are eager to provide the investment community with this useful research tool.”
Mr. Silver stated, “eFoodSafety offers investors an opportunity to potentially capitalize on treatments for some of the world’s most costly infectious diseases and conditions. Leveraging its innovative patent-pending technologies, eFoodSafety expects to bring to market treatments for multi-billion dollar conditions such as diabetes and high cholesterol, in addition to treatments for such infectious diseases as malaria and tuberculosis, which combined cost the world almost $200 billion annually.”
eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company’s Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) – EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company’s MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn™-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn™ line. The Company is also owner of Cinnergen™, a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com) and Cinnechol™, a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect™ anti-acne skin care system.
Statements contained in this release that are not strictly historical are “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company’s actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company’s products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.
About Wall Street Resources, Inc.:
Wall Street Resources, Inc. and its affiliated site http://www.wallstreetresources.net is a leading source for information on publicly traded micro-to-small capital companies. Wall Street Resources (WSR) acts as a conduit between micro-to-small capital company investors and emerging growth companies through its proprietary financial publications, including daily and monthly newsletters as well as comprehensive 20-50 page featured company reports. To sign up to receive WSR’s financial publications go to: http://www.wallstreetresources.net/signup_basic_indiv.asp. WSR also provides business consulting services to help corporate executives by writing analytical reports, building financial models, and developing business plans.
Disclaimer -- We, our affiliates, and any officer, director or stockholder or any member of their families may have a position in and may from time to time purchase or sell any securities discussed in our financial publications. There may be instances when fundamental, technical, and quantitative opinions may not be in concert. Our associates may from time to time perform investment banking or other services for, or solicit investment banking or other business from, any company mentioned in our reports. WSR is a consultant to the Company and has received $10,000 in cash and 225,000 shares of 144 restricted stock for due diligence fees and consulting services from January of 2007 through July of 2007.
